Terms: = Ovarian cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
27 results:
1. Tumor-Stroma Proportion to Predict Chemoresistance in Patients With ovarian cancer.
Lou E; Clemente V; Grube M; Svedbom A; Nelson AC; Blome F; Staebler A; Kommoss S; Bazzaro M
JAMA Netw Open; 2024 Feb; 7(2):e240407. PubMed ID: 38411963
[TBL] [Abstract] [Full Text] [Related]
2. runx1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.
Yu X; Zhao P; Luo Q; Wu X; Wang Y; Nan Y; Liu S; Gao W; Li B; Liu Z; Cui Z
Oncogene; 2024 Feb; 43(6):420-433. PubMed ID: 38092960
[TBL] [Abstract] [Full Text] [Related]
3. Therapy-related acute myeloid leukemia with
Yang X; Liu Q; Zhang R; Yang X; Wang L; Zhang Z; Li Y; Lin L
Indian J Pathol Microbiol; 2023; 66(4):865-867. PubMed ID: 38084551
[TBL] [Abstract] [Full Text] [Related]
4. runx1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells.
Chen Y; He Z; Yang S; Chen C; Xiong W; He Y; Liu S
J Transl Med; 2023 Dec; 21(1):886. PubMed ID: 38057816
[TBL] [Abstract] [Full Text] [Related]
5. Intra- and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer.
Wu Y; Jiang W; Fu L; Ren M; Ai H; Wang X
Abdom Radiol (NY); 2023 Feb; 48(2):733-743. PubMed ID: 36445408
[TBL] [Abstract] [Full Text] [Related]
6. PROM1, CXCL8, runx1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.
Dansonka-Mieszkowska A; Szafron LA; Kulesza M; Stachurska A; Leszczynski P; Tomczyk-Szatkowska A; Sobiczewski P; Parada J; Kulinczak M; Moes-Sosnowska J; Pienkowska-Grela B; Kupryjanczyk J; Chechlinska M; Szafron LM
PLoS One; 2022; 17(7):e0271539. PubMed ID: 35867729
[TBL] [Abstract] [Full Text] [Related]
7. ovarian stimulation for fertility treatments and risk of breast cancer: a matched cohort study.
Machtinger R; Fallach N; Goldstein I; Chodick G; Schiff E; Orvieto R; Mashiach R
Hum Reprod; 2022 Mar; 37(3):577-585. PubMed ID: 34871410
[TBL] [Abstract] [Full Text] [Related]
8. The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China.
Ni J; Cheng X; Zhao Q; Dai Z; Xu X; Guo W; Gu H; Zhou R; Wang Y; Chen X
J Ovarian Res; 2021 May; 14(1):68. PubMed ID: 33993885
[TBL] [Abstract] [Full Text] [Related]
9. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of runx1 promotes cisplatin-induced apoptosis in ovarian cancer cells.
Xiao L; Peng Z; Zhu A; Xue R; Lu R; Mi J; Xi S; Chen W; Jiang S
Biochem Pharmacol; 2020 Oct; 180():114116. PubMed ID: 32579960
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in ovarian cancer: A Network Meta-Analysis.
Feng Y; Huang H; Wan T; Zhang C; Tong C; Liu J
Adv Ther; 2019 Dec; 36(12):3368-3380. PubMed ID: 31599396
[TBL] [Abstract] [Full Text] [Related]
12. Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Vergote I; Coens C; Nankivell M; Kristensen GB; Parmar MKB; Ehlen T; Jayson GC; Johnson N; Swart AM; Verheijen R; McCluggage WG; Perren T; Panici PB; Kenter G; Casado A; Mendiola C; Stuart G; Reed NS; Kehoe S; ;
Lancet Oncol; 2018 Dec; 19(12):1680-1687. PubMed ID: 30413383
[TBL] [Abstract] [Full Text] [Related]
13. Angiogenesis Inhibitors for the treatment of ovarian cancer: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials.
Wang H; Xu T; Zheng L; Li G
Int J Gynecol Cancer; 2018 Jun; 28(5):903-914. PubMed ID: 29561301
[TBL] [Abstract] [Full Text] [Related]
14. Gynecologic cancer mortality in Trinidad and Tobago and comparisons of mortality-to-incidence rate ratios across global regions.
Llanos AAM; Warner WA; Luciani S; Lee TY; Bajracharya S; Slovacek S; Roach V; Lamont-Greene M
Cancer Causes Control; 2017 Nov; 28(11):1251-1263. PubMed ID: 28917021
[TBL] [Abstract] [Full Text] [Related]
15. Does the age affect the efficacy of angiogenesis inhibitors in ovarian cancer? A meta-analysis of randomized controlled trials.
Miao H; Miao CX; Han J; Li N
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3047-3053. PubMed ID: 28742202
[TBL] [Abstract] [Full Text] [Related]
16. A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.
Eoh KJ; Yoon JW; Lee JY; Nam EJ; Kim S; Kim SW; Kim YT
BMC Cancer; 2017 Jul; 17(1):481. PubMed ID: 28701190
[TBL] [Abstract] [Full Text] [Related]
17. ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast cancer.
van den Belt-Dusebout AW; Spaan M; Lambalk CB; Kortman M; Laven JS; van Santbrink EJ; van der Westerlaken LA; Cohlen BJ; Braat DD; Smeenk JM; Land JA; Goddijn M; van Golde RJ; van Rumste MM; Schats R; Józwiak K; Hauptmann M; Rookus MA; Burger CW; van Leeuwen FE
JAMA; 2016 Jul; 316(3):300-12. PubMed ID: 27434442
[TBL] [Abstract] [Full Text] [Related]
18. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract] [Full Text] [Related]
19. ERM/ETV5 and runx1/aml1 expression in endometrioid adenocarcinomas of endometrium and association with neoplastic progression.
de Sousa VP; Chaves CB; Huguenin JF; Moreira FC; de Reis BS; Chimelli L; Bergmann A; Simão Tde A; Pinto LF
Cancer Biol Ther; 2014 Jul; 15(7):888-94. PubMed ID: 24756106
[TBL] [Abstract] [Full Text] [Related]
20. Knockdown of core binding factorβ alters sphingolipid metabolism.
Greer AH; Yong T; Fennell K; Moustafa YW; Fowler M; Galiano F; Ng SW; Berkowitz RS; Cardelli J; Meyers S; Davis JN
J Cell Physiol; 2013 Dec; 228(12):2350-64. PubMed ID: 23813439
[TBL] [Abstract] [Full Text] [Related]
[Next]
